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The hypothalamic paraventricular nucleus (PVN) is the primary driver of hypothalamo– 
pituitary–adrenocortical (HPA) responses. At least part of the role of the PVN is managing 
the demands of chronic stress exposure. With repeated exposure to stress, hypophys-
iotrophic corticotropin-releasing hormone (CRH) neurons of the PVN display a remark-
able cellular, synaptic, and connectional plasticity that serves to maximize the ability 
of the HPA axis to maintain response vigor and flexibility. At the cellular level, chronic 
stress enhances the production of CRH and its co-secretagogue arginine vasopressin 
and rearranges neurotransmitter receptor expression so as to maximize cellular excit-
ability. There is also evidence to suggest that efficacy of local glucocorticoid feedback 
is reduced following chronic stress. At the level of the synapse, chronic stress enhances 
cellular excitability and reduces inhibitory tone. Finally, chronic stress causes a structural 
enhancement of excitatory innervation, increasing the density of glutamate and norad-
renergic/adrenergic terminals on CRH neuronal cell somata and dendrites. Together, 
these neuroplastic changes favor the ability of the HPA axis to retain responsiveness 
even under conditions of considerable adversity. Thus, chronic stress appears able to 
drive PVN neurons via a number of convergent mechanisms, processes that may play a 
major role in HPA axis dysfunction seen in variety of stress-linked disease states.
Keywords: corticotropin-releasing hormone, vasopressin, hypothalamo–pituitary–adrenal axis, glucocorticoids, 
neuroendocrine system
iNTRODUCTiON
The hypothalamo–pituitary–adrenocortical (HPA) axis is required for appropriate adaptation to 
external or internal challenge. The so-called HPA axis “stress response” culminates in the release of 
glucocorticoids by the adrenal gland, which acts at multiple sites throughout the body (and brain) 
to mobilize energy resources. This redistribution of energy provides essential fuels for meeting real 
or anticipated challenges to homeostasis or well being (i.e., “stressors”) (1). While important for 
immediate adaptation, prolonged exposure to glucocorticoids can create a metabolic challenge of 
its own. Consequently, activation of the HPA axis is kept in control by negative feedback, wherein 
glucocorticoids inhibit their own release (2).
The HPA axis is controlled by peptidergic neuroendocrine neurons located in the medial 
parvocellular division of the hypothalamic paraventricular nucleus (PVN) (Figure 1). These neu-
rons are responsible for the release of corticotropin-releasing hormone (CRH), which acts as the 
FigURe 1 | Plasticity across the hypothalamo–pituitary–
adrenocortical (HPA) axis following chronic stress. HPA axis activation 
is initiated by CRH (and AVP)-containing neurons in the medial parvocellular 
paraventricular nucleus (PVN), which releases ACTH secretagogues into 
hypophysial portal vessels in the median eminence. ACTH is released from 
the pituitary and travels via the systemic circulation to the adrenal cortex, 
where it causes the synthesis and secretion of glucocorticoids [e.g., cortisol 
or corticosterone (CORT)]. Under conditions of chronic stress, there are 
marked changes in cellular reactivity across the HPA axis, including (1) 
increased CRH and AVP expression in, and enhanced excitability of CRH 
neurons in the PVN, (2) increased CRH/AVP colocalization and CRH release 
in the median eminence, (3) increased CRHR1 and V1b gene expression in 
and sensitivity to CRH and AVP of pituitary corticotropes, and (4) adrenal 
hypertrophy and enhanced adrenal sensitivity to ACTH. All changes are 
consistent with increased potential for HPA axis activation. Modified from 
Myers et al. (4), with permission.
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obligate factor responsible for adrenocorticotrophic hormone 
(ACTH) release in most organisms (3). Upon stimulation, CRH 
is released into hypophysial portal vessels in the external lamina 
of the median eminence, where it is transported to the anterior 
pituitary gland to promote ACTH release. ACTH then travels via 
the systemic circulation to the adrenal cortex, where it triggers 
the synthesis and release of glucocorticoids.
Importantly, PVN CRH neurons also synthesize arginine 
vasopressin (AVP), which is co-stored and co-released with CRH 
in the median eminence (5, 6). While having minimal effects on 
its own, AVP can synergize with CRH to greatly amplify ACTH 
release (7). Under unstimulated conditions, AVP expression 
in CRH neurons is very low and likely plays a minimal role in 
ACTH secretion. However, following prolonged activation (e.g., 
adrenalectomy or as we will see below, chronic stress) (8, 9), 
parvocellular AVP production is markedly increased, suggesting 
a role in chronic drive of the HPA axis. Electron microscopy stud-
ies indicate depletion of AVP from CRH terminals in the median 
eminence following acute stress (10), consistent with co-release 
in response to drive of PVN neurons.
Both CRH and AVP act at the level of the pituitary corticotrope 
to modulate the release of ACTH. CRH binds to corticotropin-
releasing hormone R1 receptors (CRHR1), causing activation 
of adenylate cyclase and subsequent release of ACTH (11). 
Deletion of the CRH gene blocks both basal and stress-induced 
ACTH release, indicative of the obligatory nature of CRH for 
HPA axis activation (12). In contrast, AVP does not drive ACTH 
release on its own but complements the actions of CRH (via 
binding to AVP1B receptors) (13). Together, CRH and AVP 
provide for a broad range of corticotrope response following 
PVN stimulation.
It is important to note that a subset of PVN CRH neuron pro-
ject centrally and may be of functional importance in behavioral 
regulation. Lesions of the parvocellular PVN reduce anxiety-like 
behaviors in a novel environment, suggesting a role in emotional 
regulation (14). A recent study indicates that optogenetic inhibi-
tion of PVN CRH neurons reduces stress-induced grooming 
and enhances locomotion and rearing following stress, whereas 
stimulation induces grooming and reduces exploratory behaviors 
(15). Collectively, these data suggest that PVN CRH (and possibly 
AVP) neurons may be involved in coordinating behavioral as well 
as neuroendocrine responses to stress.
Parvocellular CRH neurons also express numerous other 
neuropeptides, including angiotensin II, cholecystokinin, and 
neurotensin (16). The role of these other peptides in HPA axis 
function has yet to be clarified. In addition, parvocellular PVN 
neurons have the capacity to release the excitatory neurotransmit-
ter glutamate (17). Given the presence of presynaptic glutamate 
receptors in the median eminence, it is possible that glutamate 
may also influence local release of peptide at the level of the neu-
rovascular junction (18). Indeed, blockade of GluR5-containing 
kainate receptors in the median eminence inhibits stress-induced 
ACTH release (19), suggesting a role for local glutamatergic 
signaling in HPA axis control.
The PVN is one of the primary sites of glucocorticoid negative 
feedback regulation of the HPA axis. Negative feedback is largely 
mediated by glucocorticoid receptors (GRs), which are activated 
mainly when glucocorticoid levels are elevated (e.g., during 
stress responses) (20). The GR is richly expressed in the medial 
parvocellular PVN and is co-localized with CRH (21, 22), placing 
it in prime position to control output of the very neurons that 
activate the HPA axis. Within the PVN, GR-mediated negative 
feedback of CRH neuronal activation (“fast feedback”) is likely 
mediated by non-genomic glucocorticoid signaling at or near 
the cell membrane (23, 24). Rapid inhibition of CRH neurons is 
key to limiting the duration of glucocorticoid secretion follow-
ing acute stress, as genomic feedback would not be sufficiently 
fast to terminate HPA axis activation in a timely fashion. Fast 
feedback is mediated by glucocorticoid-dependent mobilization 
of endocannabinoid production in putative CRH neurons, which 
cause inhibition of presynaptic glutamate release via retrograde 
signaling at type 1 cannabinoid (CB1) receptors (23). While there 
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is evidence to suggest that membrane effects involve the classi-
cal GR (25, 26), the exact mechanism of glucocorticoid action 
remains to be delineated (27).
Genomic feedback effects on CRH neurons likely occur at 
longer poststimulation latencies and may be mediated by ligand-
dependent nuclear translocation and subsequent interactions of 
the GR with cognate DNA binding elements or other transcrip-
tion factor complexes. Genomic actions of GR may be involved in 
glucocorticoid-mediated inhibition of CRH and AVP gene expres-
sion in hypophysiotrophic neurons following adrenalectomy (28, 
29). However, there are data to suggest that rapid effects of stress 
on CRH gene transcription may be glucocorticoid-independent. 
Rapid inhibition of CRH heteronuclear RNA (hnRNA) expres-
sion appears to be mediated by rapid stress-induced increases in 
expression of the inducible cyclic AMP early repressor (ICER) 
isoform of the cyclic AMP response element modulator (CREM), 
which binds to the CRH promoter and blocks transcription 
(30). Transcriptional repression of CRH by ICER/CREM is not 
dependent on a glucocorticoid surge, suggesting an alternative 
mechanism.
Glucocorticoids also signal through the mineralocorticoid 
receptor (MR). The MR is occupied at low circulating levels of 
glucocorticoids and is not thought to mediate glucocorticoid 
feedback effects (20). However, there are data suggesting that 
occupation of the MR is required for appropriate regulation of 
stress responses in some contexts (31), and certain rapid gluco-
corticoid actions in the hippocampus and basolateral amygdala 
are mediated by MR activation (32, 33). While there is evidence 
for MR expression in the medial parvocellular PVN (34), its role 
in the local regulation of HPA axis function is unexplored.
CHRONiC STReSS-iNDUCeD 
NeUROPePTiDeRgiC PLASTiCiTY  
iN THe PvN
Chronic exposure to stress produces regimen-dependent altera-
tions in PVN production of CRH mRNA. Most stressors that 
involve non-social interventions (e.g., repeated immobilization, 
repeated footshock, chronic unpredictable/variable stress, 
repeated predator exposure) produce upregulation of PVN CRH 
mRNA expression (9, 35–37). For example, in our hands, we have 
observed increased PVN CRH mRNA expression in all studies 
using chronic variable stress (1- to 4-week exposure to a random 
assort of stressors twice/day, at unpredictable times) (38–41). 
Indeed, the magnitude of CRH mRNA upregulation is remark-
ably similar across studies (generally falling between 40 and 60%), 
despite studies being conducted at two different institutions and 
over several years (38–41). Thus, it is evident that increased drive 
to the PVN effectively enhances CRH gene expression in these 
regimens. The exact mechanism driving elevations in CRH gene 
expression is not completely understood but probably involves 
increases in transcription mediated by repeated activation of 
cAMP (42, 43). Transcription may be partially (but not com-
pletely) counter-balanced by enhanced glucocorticoid-mediated 
degradation of CRH mRNA (44), likely as a feedback homeostatic 
control mechanism.
The impact of chronic stress on CRH gene transcription is 
accompanied by enhanced CRH peptide production in PVN 
cell bodies and decreased storage in the median eminence (45). 
The latter observation suggests an increase in turnover of CRH, 
which is consistent with chronic activation. In the cell soma, 
increased peptide synthesis is accompanied by an increase in the 
physical size of the CRH neurons (46), similar to that seen in 
magnocellular AVP and oxytocin neurons following dehydration 
and lactation (47, 48). Increased cell size may reflect a general 
drive on transcription and protein synthesis, perhaps as a way of 
adapting to increased energetic demand. These data are consistent 
with increase in protein synthesis as well as in capacity for release, 
which may partially underlie baseline glucocorticoid hypersecre-
tion and stress facilitation seen following chronic stress (below).
Chronic stress also increases AVP gene transcription in 
parvocellular PVN neurons (49). The dynamics of chronic stress-
induced AVP and CRH transcriptional responses differ consider-
ably. Exposure to habituating, homotypic stressors (e.g., restraint) 
results in the loss of PVN CRH transcriptional responses over 
time, in terms of both hnRNA and mRNA expression (50). 
Moreover, CRH neurons lose the ability to mount transcriptional 
responses to a novel acute (heterotypic) stress (e.g., hypertonic 
saline) following repeated stress exposure. In contrast, while 
AVP hnRNA and mRNA responses also habituate with repeated 
restraint, robust transcriptional responses are observed when 
challenged with a heterotypic stressor, stronger than that seen 
in stress-naïve controls (49). Together, the data suggest that 
AVP may play an important role in maintaining or potentiating 
PVN (and by extension, HPA axis) drive after homotypic stress 
exposure.
Chronic variable stress reduces expression of the GR in the 
medial parvocellular PVN. Since both CRH and AVP gene/
protein expression are negatively regulated by glucocorticoids, 
it is possible that reduced GR may play a role in the observed 
upregulation of both genes during chronic stress. Indeed, expres-
sion of GR is negatively correlated with CRH mRNA in the PVN 
(9, 51), suggestive of a mechanism for stress-induced upregula-
tion. However, it is important to note that downregulation of GR 
mRNA is not observed in all stress regimens, despite elevated 
CRH, suggesting that other mechanisms may also contribute to 
driving PVN gene expression. In this regard, it is important to 
note that the efficacy of GR signaling may be negatively modu-
lated by posttranscriptional mechanisms. For example, nuclear 
GR signaling can be affected at the level of receptor translocation 
(as seen in aging) (52) or binding to nuclear factors that modulate 
transcriptional activity (53). Regarding the latter possibility, GR 
binding to different isoforms of steroid receptor coactivator 
protein 1 can dramatically affect the transcription of CRH and 
CRH gene methylation (54).
CeLLULAR iMPACT OF CHRONiC STReSS 
ON MeDiAL PARvOCeLLULAR PvN 
NeURONS
Chronic stress produces multiple cellular adaptations in 
CRH neurons that are consistent with enhanced excitability 
FigURe 2 | Cellular plasticity in parvocellular paraventricular nucleus neurons following chronic stress. Chronic stress causes a number of neuroplastic 
changes in parvocellular neurons consistent with increased excitability, including (1) increased number of (excitatory) glutamergic (VGluT2) terminal appositions, (2) 
enhanced excitatory synaptic inputs (increase in mEPSC frequency), (3) enhanced NR2A/NR2B ratio, predictive of increased NMDA receptor calcium permeability, 
and (4) increased number of (putative excitatory) norepinephrine/epinephrine terminal appositions. In addition, there is evidence for reduced inhibition of the PVN 
neurons, in terms of (1) reduced GABAergic synaptic inputs (decrease in mIPSC frequency), (2) decreased expression of synaptic and extrasynaptic GABAA receptor 
subunits, (3) decreased cannabinoid type 1 receptor signaling, and (4) reduced GR expression/signaling, in some, but not all, studies.
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(Figure  2). Chronic variable stress reduces mIPSC frequency 
(but not amplitude) in putative CRH neurons, indicative of loss 
of inhibitory inputs (55, 56). Chronic variable stress exposure 
also decreases the expression of GABAA receptor α5, β1, β2, and 
δ subunits (55, 57), consistent with reduced GABAergic inhibi-
tion. Importantly, receptors expressing δ subunits are largely 
extrasynaptic and are thought to mediate tonic inhibition (58). 
The loss of extrasynaptic receptors, therefore, would be expected 
to reduce tonic GABAergic inhibition of PVN neurons. In addi-
tion, there is evidence supporting a reversal of chloride current 
in CRH neurons after stress exposure, essentially rendering 
GABA less effective at the GABAA receptor and resulting in 
reduced synaptic inhibition (59). Loss of inhibitory GABAergic 
transmission is linked to marked glucocorticoid-dependent 
downregulation of the potassium-chloride co-transporter, 
KCC2, resulting in enhanced intracellular chloride ion con-
centration and a weakened membrane chloride gradient (59). 
Notably, chronic variable stress also causes downregulation of 
KCC2 in CRH neurons, consistent with lasting impairments in 
inhibitory GABA signaling (60).
There is evidence to suggest enhanced excitability of PVN 
neurons following chronic stress. Baseline excitatory drive 
of parvocellular PVN neurons is enhanced by chronic stress 
exposure, manifest as increased mEPSC frequency (56). In 
addition, ionotrophic N-methyl-d-aspartate receptor subunits 
are modulated by chronic variable stress in a manner consistent 
with enhanced postsynaptic glutamate receptivity. Chronic stress 
causes a selective decrease in expression of NR2B in the medial 
parvocellular PVN, whereas NR1 and NR2A expression are 
unaffected. As calcium permeability of NR2A containing chan-
nels is greater than that of NR2b channels, these data predict an 
enhanced excitability of the NMDA receptor complex following 
chronic stress (61).
Enhanced PVN excitability may also be affected by chronic 
stress-induced loss of endocannabinoid signaling in PVN 
afferents. Animals exposed to chronic restraint stress lose 
 depolarization-induced suppression of both glutamate and 
GABA release at parvocellular PVN neurons (62). Given the 
reversal of the chloride gradient following chronic stress, 
both effects are consistent with reduced inhibition of PVN 
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neurons. Loss of inhibitory control appears to be mediated by a 
GR-dependent inhibition of CB1 receptor signaling, likely medi-
ated by the loss of CB1 terminals on PVN neurons. Thus, chronic 
restraint stress likely produces a loss of presynaptic cannabinoid 
inhibition, effectively blocking endocannabinoid-mediated 
glucocorticoid-dependent fast feedback inhibition of the HPA 
axis (62). However, it is important to note that glucocorticoid-
induced endocannabinoid signaling is not affected following 
chronic variable stress (56), indicating that different mechanisms 
may regulate PVN responses under conditions of predictable vs. 
unpredictable stress exposure.
Chronic stress exposure affects markers of cellular activation 
in the PVN. Neuronal activation causes rapid induction of the 
immediate early gene, cfos, largely as the result of depolarization 
(63, 64). The resulting protein, Fos, binds with other cofactors of 
the jun family to form a potent transcriptional activation complex 
acting at activator protein 1 (AP1) response elements on DNA 
(65). Not surprisingly, acute stress produces a marked increase 
in PVN cfos mRNA/Fos expression, consistent with cellular acti-
vation (63, 64). However, the acute Fos response to homotypic 
stressor exposure (e.g., restraint, noise) wanes over repeated 
exposure (66–68), suggesting habituation of cellular activation. 
In contrast, PVN cfos gene expression/Fos protein induction by a 
heterotypic stressor is preserved or enhanced in some paradigms 
[e.g., chronic cold plus acute restraint (69)] but not others [e.g., 
chronic variable stress plus novelty, chronic social stress plus open 
arm (elevated plus maze) exposure] (70, 71). The fact that the 
acute Fos activation is reduced in the latter paradigms indicates 
some degree of cross-habituation to stressor exposure, at least 
as far as Fos induction is concerned. The lower cfos mRNA/Fos 
response may also be associated with the relative (low) intensity 
of the evocative stimuli with respect to other stimuli occuring in 
the unpredictable stress or social stress paradigms. Of course, it 
is important to consider that the magnitude of the Fos response 
may not be an accurate reporter of cellular activation in the 
context of repeated drive, given that other intracellular changes 
[e.g., increased CRH expression (68), enhanced excitability (56)] 
may compensate for habituation in the AP1 pathway.
Chronic stress also causes enduring changes in immediate 
early gene family members, consistent with chronic activation. 
For example, expression of FosB/delta FosB, a Fos family member 
that aggregates in the cell over repeated activations, is upregulated 
in the PVN by morphine withdrawal (72).
CHRONiC STReSS NeUROPLASTiCiTY 
OF PvN iNPUTS
Chronic stress-induced enhancement of PVN response capacity 
may be driven in large part by neuroplasticity in afferent con-
nections (Figure 2). Work from our group suggests that chronic 
variable stress increases glutamatergic inputs to CRH neurons, as 
determined by elevations in the number of vesicular glutamate 
transporter 2 (VGluT2) appositions onto both dendrites and 
somata (46) and increases in excitatory synaptic inputs to PVN 
neurons (56). Both observations suggest that the enhanced drive 
is mediated by additional synaptic contacts. Moreover, early-life 
maternal enrichment, which is linked to reduced stress reactiv-
ity, decreases VGluT2 synaptic contacts and excitatory synaptic 
inputs in CRH neurons (73), further suggesting that the glutamate 
innervation is an important determinant of PVN excitability.
Chronic stress also increases the number of dopamine beta 
hydroxylase-positive appositions with CRH dendrites and 
somata, consistent with enhanced noradrenergic (and adren-
ergic) innervation (46). A sizable body of evidence suggests 
that PVN norepinephrine (NE) drives HPA axis responses in a 
stressor-dependent fashion (74, 75), suggesting the capacity for 
stress-induced enhancement of NE innervation to drive CRH 
neurons. Lesion of PVN-projecting NE/E neurons using DBH-
conjugated saporin (DSAP) reduces ACTH responses to an acute 
stress in rats previously exposed to chronic variable stress, indi-
cating that adrenergic input is required for the excitatory drive of 
CRH neurons under these conditions. However, corticosterone 
responses are not affected by PVN NE/E depletion, consistent 
with compensation at the level of the adrenal gland (see below) 
(76). Notably, DSAP also blocks chronic stress-induced increases 
in PVN synaptophysin and VGluT2 expression, suggesting that 
lesions may interfere with glutamatergic neuroplasticity (76).
Subsequent studies have compared the impact of chronic 
stress on PVN innervation in males and females. Overall, medial 
parvocellular PVN innervation, determined from the density 
of synaptophysin staining, is greater in females than in males. 
However, in response to chronic stress, synaptic density mark-
edly increases in males but decreases in females (77). Enhanced 
PVN innervation in males is accompanied by increased 
VGluT2 innervation of CRH neurons (unpublished data). 
Despite clear evidence for chronic stress-induced decrements 
in inhibitory synaptic inputs (55, 56), we did not observe a loss 
of GABAergic appositions onto CRH neurons in either males or 
females (unpublished data). These results suggest that the loss 
of GABAergic input to PVN neurons may not be simply due to 
reduced synaptic afferents but rather may reflect differences in 
release probability. Chronic stress effects on GABAergic inputs 
may also be connected to modifications in GABAergic signaling 
efficacy, mediated by sex differences in postsynaptic reversal of 
chloride gradients or reduced efficacy of presynaptic CB1 signal-
ing, noted above. These data imply a marked difference in PVN 
synaptic physiology in males and females, the significance of 
which remains to be evaluated.
Not all presynaptic changes are linked to enhanced excitability. 
Work from our group has demonstrated that glucagon-like pep-
tide 1 (GLP-1) inputs to the PVN (from the caudal nucleus of the 
solitary tract) are powerful drivers of HPA axis stress responses 
(78, 79). Moreover, exogenous GLP-1 enhances HPA axis facilita-
tion following chronic variable stress, suggesting a role in driving 
CRH neuronal responsiveness (79). However, chronic stress 
results in profound inhibition of the expression of the GLP-1 pre-
cursor preproglucagon (PPG) in NTS neurons, accompanied by 
loss of GLP-1 innervation to the medial parvocellular PVN (80). 
Reduction of PPG gene expression is glucocorticoid-dependent, 
suggesting that chronic stress-induced glucocorticoid secretion 
removes an important excitatory drive to the PVN (80). Removal 
of GLP-1 PVN innervation may represent a feedback mechanism 
that limits excessive drive of the HPA axis following chronic stress.
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CHRONiC STReSS AND PvN AFFeReNTS
The PVN gates output of the HPA axis, acting essentially as a 
“final common pathway.” Consequently, PVN output is subject 
to upstream changes in stress-sensitive projections (81). Lesion 
studies suggest that damage to key limbic structures following 
chronic stress causes marked changes in PVN activation. Damage 
to the posterior subregion of the bed nucleus of the stria terminals 
potentiates HPA axis stress responses and increases PVN cfos 
gene expression following chronic variable stress. The posterior 
BST provides strong GABAergic input to the PVN, suggesting 
that chronic stress reduces BST inhibition of the HPA axis (82). 
However, lesions of the anterior subregion of the BST reduce HPA 
axis responses to acute stress but enhance ACTH release and 
PVN cfos mRNA expression following chronic stress, consistent 
with a change in the functional connectivity of this region with 
the PVN as a result of repeated stress (83). The anterior BST sends 
both excitatory (CRH-containing) and inhibitory (GABAergic) 
projections to the PVN (84, 85), raising the possibility that the 
relative weighting of these inputs is modified by repeated stress 
exposure.
Lesions of the paraventricular thalamic nucleus (PVT) have 
profound effects on both habituation and sensitization of the 
HPA axis and PVN responses to stress (86). This region of the 
limbic thalamus does not connect directly with the PVN and thus 
requires intermediary relays to access CRH neurons. Damage to 
the PVT has no effect on acute stress responses but blocks chronic 
stress-induced facilitation of HPA axis responses and PVN Fos 
induction to a novel stress (86). Moreover, damage to this region 
blocks habituation of HPA axis responses to repeated stressor 
exposure (86). These data indicate a role for this structure in 
relaying information on stress chronicity to the PVN.
It is of interest to note that regions controlling acute stress 
reactivity do not necessarily modulate chronic stress responses. 
Lesions of the central nucleus of the amygdala, locus coeruleus, or 
ventral subiculum have no effect on somatic end points, HPA axis 
activity, or PVN neuropeptide plasticity following chronic stress, 
despite profound actions on acute stress reactivity (38, 39). Thus, 
circuits mediating PVN plasticity following chronic stress may 
differ from those controlling acute reactivity.
We recently used FosB immunostaining to map brain regions 
selectively activated by chronic variable stress, as compared to 
a chronic heterotypic (habituation) stress regimen (restraint). 
Our data identified a small set of interconnected structures that 
expressed FosB after chronic variable stress: the infralimbic 
cortex (IL), posterior hypothalamus, and NTS (87). Both the 
posterior hypothalamus and NTS are connected with the IL and 
send excitatory projections to the PVN (88–90), consistent with 
a possible role in potentiation of the excitatory drive to the HPA 
axis following chronic stress.
Selective inhibition of GR signaling further implicates two of 
these brain regions, the IL and NTS, in alterations to PVN drive 
by chronic stress. Lentiviral knockdown of GR in the IL (but not 
prelimbic cortex) produces a marked potentiation of HPA axis and 
PVN Fos induction to a novel stress in animals exposed to CVS 
(91), a phenomenon linked to interneuron-mediated decreases in 
IL output (92). Implants of the GR antagonist mifepristone in the 
NTS inhibit PVN excitability following chronic stress, suggesting 
that the glucocorticoids may play a role in inhibiting the NTS 
drive to the PVN (93). These data implicate both regions as sites 
of glucocorticoid feedback (perhaps at the genomic level) and 
suggest that they function to set HPA reactivity consequent to 
chronic stress.
iMPACT OF CHRONiC STReSS ON  
PvN OUTPUT
Chronic stress leaves a cumulative record of HPA activation, 
including adrenal hypertrophy (due to elevated ACTH exposure), 
thymic atrophy (as a result of glucocorticoid-mediated cell death), 
and increased PVN FosB/delta FosB expression. All effects are 
believed to be a direct consequence of central drive of CRH neu-
rons by stressors. However, it is important to consider the dynam-
ics that underlie the progression of chronic stress endpoints. In 
general, the largest somatic and HPA axis effects are observed in 
the first few days of a chronic stress regimen. For example, expo-
sure to chronic social stress causes a profound initial weight loss 
that is then maintained across the duration of the stress regimen 
(94). Similarly, increases in resting glucocorticoid secretion are 
greatest across the first few days of chronic stress and can dimin-
ish significantly over time. Given evidence for adaptation within 
chronic stress regimens, it is likely that the enduring effects of 
chronic stress on PVN activation are mediated by a combination 
of marginal increases in baseline drive and episodic activation of 
CRH neurons as a result of each stress exposure.
It is important to note that chronic stress activation of the 
HPA axis may be adjusted downstream of the CRH neuron 
(Figure 1). Chronic stress results in marked changes in pituitary 
corticotropes, including an upregulation of proopiomelanocor-
tin (ACTH precursor protein) synthesis and increases in both 
CRHR1 and vasopressin 1b (V1b) receptor mRNA expression 
(13, 95), suggesting mechanisms that would enhance capacity for 
ACTH release. Interestingly, chronic stress triggers increases in 
pituitary V1b, but not CRHR1 binding, again predicting a role for 
AVP in potentiation of stress responses at the level of the pitui-
tary (11). We recently reported an increase in the sensitivity of 
pituitary ACTH secretion to CRH stimulation in vivo and in vitro 
following chronic variable stress (56).
Chronic stress also causes changes at the level of the adrenal 
cortex. Exposure to 2 weeks of chronic variable stress results in 
marked hyperplasia and hypertrophy of the adrenal gland, as 
well as a marked enhancement of adrenal sensitivity to ACTH 
(96). Prior studies indicated that adrenal sensitivity to ACTH is 
modified by splanchnic nerve cuts (which remove innervation 
of the adrenal cortex) (97), suggesting that chronic stress-related 
changes in adrenal size and responsiveness are mediated by 
increased sympathetic activation.
There are marked differences in HPA axis regulatory mecha-
nisms in males and females. Basal total corticosterone levels 
are higher in females than in males [e.g., Figueiredo et al. (98)]. 
However, circulating corticosteroid-binding globulin is higher in 
females than males, with the net effect of negating the sex dif-
ferences in resting corticosterone levels (however, stress-induced 
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free corticosterone remains higher in females than males) (99). In 
addition, estrogens play a major role in driving HPA axis activation 
in females and are responsible for elevated glucocorticoids during 
proestrus and estrus in rodents (98, 100, 101). Interestingly, the 
effect of estrogens on the HPA axis is particularly pronounced at 
the level of the adrenal gland: estradiol inhibits restraint-induced 
ACTH release but strongly enhances the sensitivity of the adrenal 
to ACTH, which results in a net increase in stress-induced gluco-
corticoid release (102).
ALTeRNATive PvN ReSPONSeS  
TO CHRONiC STReSS: SOCiAL 
SUBORDiNATiON
While upregulation of PVN function is commonly observed 
after most chronic stress regimens, it is important to note that 
stress regimens with strong social or metabolic components 
produce more variable results. For example, in rats, chronic 
social stress appears to decrease PVN CRH mRNA expression 
in subpopulations of subordinate individuals (103). Decreased 
CRH mRNA is observed in individuals that exhibit short defeat 
latencies to repeated social defeat and in individuals showing a 
 stress-non-responsive phenotype in a colony-based subordina-
tion paradigm (104), suggesting an enhanced downregulation of 
response capacity in the most severely affected animals. In mice, 
results have been more variable. Some studies report upregula-
tion of CRH mRNA, particularly in subsets of animals that do 
not engage the resident in a repeated intruder stress paradigm 
(designated as “stress-susceptible” individuals) (105). Chronic 
social stress (housing with aggressive conspecific) results in 
transient CRH mRNA increases that normalize over time, despite 
subsequent development of severe adrenal insufficiency (106). 
Other studies do not report changes in CRH following repeated 
defeat stress (although samples were not stratified with respect 
to submissive behaviors) (107). However, social stress-induced 
increases in AVP mRNA expression have been reported by 
multiple groups (107–109), once again suggesting that prolonged 
activation of the HPA axis during social stress may be driven by 
this important ACTH co-secretagogue.
Unfortunately, the data on PVN function following social 
stress are largely limited to gene expression, limiting appreciation 
of cellular and neuroplastic adaptations that may be important 
to understanding mechanisms underlying social stress and its 
related pathologies. Moreover, these studies do not explore 
possible dynamic changes in PVN glucocorticoid signaling 
that are specific to social stress. These interesting discrepancies 
between PVN responses to environmentally imposed and social 
stress require additional attention, as they may inform essential 
differences between diseases linked to HPA axis hyper- vs. hypo-
responsiveness (e.g., depression vs. PTSD/chronic fatigue).
SUMMARY
The weight of evidence overwhelmingly supports a dynamic 
neuroplasticity in the PVN as a result of chronic stress. Chronic 
stress has a demonstrable impact on cellular biosynthetic activ-
ity (cell size, neuropeptide expression); cell physiology (reduced 
inhibition and enhanced excitation); neurotransmission (recep-
tor expression, innervation patterns); glucocorticoid feedback 
(rapid and genomic, local and upstream); and storage and release 
of ACTH secretagogues in the median eminence. Nearly all of 
these changes are predictive of enhanced potential for CRH and 
co-secretagogue release, which would be instrumental in driving 
HPA axis activity. Many of the most dramatic effects are related 
to upregulation of AVP signaling capacity in CRH neurons and 
at the pituitary, and underscore the potential importance of this 
co-localized and co-released peptide as an amplifier of the CRH 
signal normally initiated by these neurons. The mechanisms in 
place for promoting CRH neuronal activity occur in the context 
of a heightened glucocorticoid signal, indicating that neural 
drive is sufficient to largely overcome feedback inhibition under 
conditions of chronic stress. All of these findings highlight the 
importance of maintaining HPA axis stress reactivity even in the 
context of chronic stress, thereby defending the organism from 
real or perceived adversity.
Enhancement of the “potential energy” of the HPA axis is 
likely adaptive within the context of a period of prolonged, but 
manageable adversity. Indeed, upregulation of the PVN may be 
thought of as a component of “allostatic load,” an “adaptation 
through change” that keeps the system on line in the event of 
need (110). However, conditions of prolonged drive may have the 
capacity to push the system beyond the point of “adaptative” value 
and contribute to psychological and physiological pathologies 
associated with chronic stress. Likewise, prolonged engagement 
of PVN drive in the absence of an appropriate context would be 
sufficient to promote pathological features of HPA axis activation 
under inappropriate (e.g., non-stressed) conditions, as observed 
in diseases linked to stress (e.g., enhanced CRH and AVP 
mRNA expression and impaired dexamethasone suppression in 
depression).
Overall, as the “final common pathway” for stress integration 
by the brain, the PVN is ultimately responsible for both normal 
and pathological features of HPA axis stress responses. Despite 
progress to date, mechanisms underlying chronic stress-related 
PVN drive, modification of PVN secretagogue signaling, and 
synaptic plasticity are ill-defined. The significance of sex differ-
ences in PVN function is virtually unexplored. Failure to address 
these key issues in what is arguably the simplest component of 
stress reactivity imperils our ability to develop strategies to miti-
gate stress and diseases of stress adaptation.
AUTHOR CONTRiBUTiONS
Dr. JH wrote the article, along with intellectual and editorial 
contributions from Dr. JT.
FUNDiNg
Work described in this review received support from MH049698 
(JH), MH069860 (JH), MH101729 (JH), MH066958 (JT), and 
MH69879 (JT).
8Herman and Tasker Stress and Paraventricular Nucleus Neuroplasticity
Frontiers in Endocrinology | www.frontiersin.org October 2016 | Volume 7 | Article 137
ReFeReNCeS
1. Myers B, Mcklveen JM, Herman JP. Glucocorticoid actions on synapses, 
circuits, and behavior: implications for the energetics of stress. Front 
Neuroendocrinol (2014) 35:180–96. doi:10.1016/j.yfrne.2013.12.003 
2. Keller-Wood ME, Dallman MF. Corticosteroid inhibition of ACTH secre-
tion. Endocr Rev (1984) 5:1–24. doi:10.1210/edrv-5-1-1 
3. Antoni FA. Hypothalamic control of adrenocorticotropin secretion: advances 
since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 
(1986) 7:351–78. doi:10.1210/edrv-7-4-351 
4. Myers B, Mcklveen JM, Herman JP. Neural regulation of the stress response: 
the many faces of feedback. Cell Mol Neurobiol (2012) 32:683–94. doi:10.1007/
s10571-012-9801-y 
5. Whitnall MH, Mezey E, Gainer H. Co-localization of corticotropin-releasing 
factor and vasopressin in median eminence neurosecretory vesicles. Nature 
(1985) 317:248–50. doi:10.1038/317248a0 
6. Antoni FA. Vasopressinergic control of pituitary adrenocorticotropin secre-
tion comes of age. Front Neuroendocrinol (1993) 14:76–122. doi:10.1006/
frne.1993.1004 
7. Gillies GE, Linton EA, Lowry PJ. Corticotropin-releasing activity of the new 
CRF is potentiated several times by vasopressin. Nature (1982) 299:355–7. 
doi:10.1038/299355a0 
8. Herman JP. In situ hybridization analysis of vasopressin gene transcrip-
tion in the paraventricular and supraoptic nuclei of the rat: regulation by 
stress and glucocorticoids. J Comp Neurol (1995) 363:15–27. doi:10.1002/
cne.903630103 
9. Herman JP, Adams D, Prewitt C. Regulatory changes in neuroendocrine 
stress-integrative circuitry produced by a variable stress paradigm. 
Neuroendocrinology (1995) 61:180–90. doi:10.1159/000126839 
10. Whitnall MH. Stress selectively activates the vasopressin-containing subset 
of corticotropin-releasing hormone neurons. Neuroendocrinology (1989) 
50:702–7. doi:10.1159/000125302 
11. Aguilera G. Regulation of pituitary ACTH secretion during chronic stress. 
Front Neuroendocrinol (1994) 15:321–50. doi:10.1006/frne.1994.1013 
12. Muglia LJ, Bethin KE, Jacobson L, Vogt SK, Majzoub JA. Pituitary-adrenal 
axis regulation in CRH-deficient mice. Endocr Res (2000) 26:1057–66. 
doi:10.3109/07435800009048638 
13. Rabadan-Diehl C, Kiss A, Camacho C, Aguilera G. Regulation of messen-
ger ribonucleic acid for corticotropin releasing hormone receptor in the 
pituitary during stress. Endocrinology (1996) 137:3808–14. doi:10.1210/
endo.137.9.8756551 
14. Herman JP, Thomas GJ, Wiegand SJ, Gash DM. Lesions of parvocellular 
subdivisions of the hypothalamic paraventricular nucleus alter open field 
behavior and acquisition of sensory and spatial discrimination. Brain Res 
(1991) 550:291–7. doi:10.1016/0006-8993(91)91331-T 
15. Fuzesi T, Daviu N, Wamsteeker Cusulin JI, Bonin RP, Bains JS. Hypothalamic 
CRH neurons orchestrate complex behaviours after stress. Nat Commun 
(2016) 7:11937. doi:10.1038/ncomms11937 
16. Swanson LW, Sawchenko PE, Lind RW, Rho JH. The CRH motoneuron: 
differential peptide regulation in neurons with possible synaptic, paracrine, 
and endocrine outputs. Ann N Y Acad Sci (1987) 512:12–23. doi:10.111
1/j.1749-6632.1987.tb24948.x 
17. Hrabovszky E, Wittmann G, Turi GF, Liposits Z, Fekete C. Hypophysiotropic 
thyrotropin-releasing hormone and corticotropin-releasing hormone 
neurons of the rat contain vesicular glutamate transporter-2. Endocrinology 
(2005) 146:341–7. doi:10.1210/en.2004-0856 
18. Hrabovszky E, Deli L, Turi GF, Kallo I, Liposits Z. Glutamatergic innervation 
of the hypothalamic median eminence and posterior pituitary of the rat. 
Neuroscience (2007) 144:1383–92. doi:10.1016/j.neuroscience.2006.10.053 
19. Evanson NK, Van Hooren DC, Herman JP. GluR5-mediated glutamate 
signaling regulates hypothalamo-pituitary-adrenocortical stress responses at 
the paraventricular nucleus and median eminence. Psychoneuroendocrinology 
(2009) 34:1370–9. doi:10.1016/j.psyneuen.2009.04.011 
20. Reul JM, de Kloet ER. Two receptor systems for corticosterone in rat 
brain: microdistribution and differential occupation. Endocrinology (1985) 
117:2505–11. doi:10.1210/endo-117-6-2505 
21. Liposits Z, Uht RM, Harrison RW, Gibbs FP, Paull WK, Bohn MC. 
Ultrastructural localization of glucocorticoid receptor (GR) in hypothalamic 
paraventricular neurons synthesizing corticotropin releasing factor (CRF). 
Histochemistry (1987) 87:407–12. doi:10.1007/BF00496811 
22. Uht RM, Mckelvy JF, Harrison RW, Bohn MC. Demonstration of glucocorti-
coid receptor-like immunoreactivity in glucocorticoid-sensitive vasopressin 
and corticotropin-releasing factor neurons in the hypothalamic paraventric-
ular nucleus. J Neurosci Res (1988) 19(405–411):468–9. 
23. Di S, Malcher-Lopes R, Halmos KC, Tasker JG. Nongenomic glucocorticoid 
inhibition via endocannabinoid release in the hypothalamus: a fast feedback 
mechanism. J Neurosci (2003) 23:4850–7. 
24. Tasker JG, Herman JP. Mechanisms of rapid glucocorticoid feedback inhi-
bition of the hypothalamic-pituitary-adrenal axis. Stress (2011) 14:398–406. 
doi:10.3109/10253890.2011.586446 
25. Nahar J, Haam J, Chen C, Jiang Z, Glatzer NR, Muglia LJ, et al. Rapid nonge-
nomic glucocorticoid actions in male mouse hypothalamic neuroendocrine 
cells are dependent on the nuclear glucocorticoid receptor. Endocrinology 
(2015) 156:2831–42. doi:10.1210/en.2015-1273 
26. Solomon MB, Loftspring M, De Kloet AD, Ghosal S, Jankord R, Flak JN, 
et al. Neuroendocrine function after hypothalamic depletion of glucocorti-
coid receptors in male and female mice. Endocrinology (2015) 156:2843–53. 
doi:10.1210/en.2015-1276 
27. Nahar J, Rainville JR, Dohanich GP, Tasker JG. Further evidence for a 
membrane receptor that binds glucocorticoids in the rodent hypothalamus. 
Steroids (2016) 114:33–40. doi:10.1016/j.steroids.2016.05.013 
28. Sawchenko PE. Evidence for a local site of action for glucocorticoids in 
inhibiting CRF and vasopressin expression in the paraventricular nucleus. 
Brain Res (1987) 403:213–23. doi:10.1016/0006-8993(87)90058-8 
29. Sawchenko PE. Adrenalectomy-induced enhancement of CRF and vasopres-
sin immunoreactivity in parvocellular neurosecretory neurons: anatomic, 
peptide, and steroid specificity. J Neurosci (1987) 7:1093–106. 
30. Shepard JD, Liu Y, Sassone-Corsi P, Aguilera G. Role of glucocorticoids and 
cAMP-mediated repression in limiting corticotropin-releasing hormone 
transcription during stress. J Neurosci (2005) 25:4073–81. doi:10.1523/
JNEUROSCI.0122-05.2005 
31. Cole MA, Kalman BA, Pace TW, Topczewski F, Lowrey MJ, Spencer RL. 
Selective blockade of the mineralocorticoid receptor impairs hypothalamic- 
pituitary-adrenal axis expression of habituation. J Neuroendocrinol (2000) 
12:1034–42. doi:10.1046/j.1365-2826.2000.00555.x 
32. Karst H, Berger S, Turiault M, Tronche F, Schutz G, Joels M. Mineralocorticoid 
receptors are indispensable for nongenomic modulation of hippocampal 
glutamate transmission by corticosterone. Proc Natl Acad Sci U S A (2005) 
102:19204–7. doi:10.1073/pnas.0507572102 
33. Karst H, Berger S, Erdmann G, Schutz G, Joels M. Metaplasticity of amygda-
lar responses to the stress hormone corticosterone. Proc Natl Acad Sci U S A 
(2010) 107:14449–54. doi:10.1073/pnas.0914381107 
34. Arriza JL, Simerly RB, Swanson LW, Evans RM. Neuronal mineralocorticoid 
receptor as a mediator of glucocorticoid response. Neuron (1988) 1:887–900. 
doi:10.1016/0896-6273(88)90136-5 
35. Imaki T, Nahan JL, Rivier C, Sawchenko PE, Vale W. Differential regulation of 
corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids 
and stress. J Neurosci (1991) 11:585–99. 
36. Mamalaki E, Kvetnansky R, Brady LS, Gold PW, Herkenham M. Repeated 
immobilization stress alters tyrosine hydroxylase, corticotropin-releasing 
hormone and corticosteroid receptor messenger ribonucleic acid levels in 
rat brain. J Neuroendocrinol (1992) 4:689–99. doi:10.1111/j.1365-2826.1992.
tb00220.x 
37. Figueiredo HF, Bodie BL, Tauchi M, Dolgas CM, Herman JP. Stress integration 
after acute and chronic predator stress: differential activation of central stress 
circuitry and sensitization of the hypothalamo-pituitary-adrenocortical axis. 
Endocrinology (2003) 144:5249–58. doi:10.1210/en.2003-0713 
38. Prewitt CM, Herman JP. Hypothalamo-pituitary-adrenocortical regulation 
following lesions of the central nucleus of the amygdala. Stress (1997) 
1:263–80. doi:10.3109/10253899709013746 
39. Ziegler DR, Cass WA, Herman JP. Excitatory influence of the locus coe-
ruleus in hypothalamic-pituitary-adrenocortical axis responses to stress. 
J Neuroendocrinol (1999) 11:361–9. doi:10.1046/j.1365-2826.1999.00337.x 
40. Solomon MB, Jones K, Packard BA, Herman JP. The medial amygdala 
modulates body weight but not neuroendocrine responses to chronic stress. 
J Neuroendocrinol (2010) 22:13–23. doi:10.1111/j.1365-2826.2009.01933.x 
9Herman and Tasker Stress and Paraventricular Nucleus Neuroplasticity
Frontiers in Endocrinology | www.frontiersin.org October 2016 | Volume 7 | Article 137
41. Jankord R, Solomon MB, Albertz J, Flak JN, Zhang R, Herman JP. Stress 
vulnerability during adolescent development in rats. Endocrinology (2011) 
152:629–38. doi:10.1210/en.2010-0658 
42. Itoi K, Horiba N, Tozawa F, Sakai Y, Sakai K, Abe K, et  al. Major role of 
3′,5′-cyclic adenosine monophosphate-dependent protein kinase A pathway 
in corticotropin-releasing factor gene expression in the rat hypothalamus 
in vivo. Endocrinology (1996) 137:2389–96. doi:10.1210/en.137.6.2389 
43. Aguilera G, Kiss A, Liu Y, Kamitakahara A. Negative regulation of corticotro-
pin releasing factor expression and limitation of stress response. Stress (2007) 
10:153–61. doi:10.1080/10253890701391192 
44. Ma XM, Camacho C, Aguilera G. Regulation of corticotropin-releasing 
hormone (CRH) transcription and CRH mRNA stability by glucocorticoids. 
Cell Mol Neurobiol (2001) 21:465–75. doi:10.1023/A:1013863205647 
45. Chappell PB, Smith MA, Kilts CD, Bissette G, Ritchie J, Anderson C, et al. 
Alterations in corticotropin-releasing factor-like immunoreactivity in 
discrete rat brain regions after acute and chronic stress. J Neurosci (1986) 
6:2908–14. 
46. Flak JN, Ostrander MM, Tasker JG, Herman JP. Chronic stress-induced 
neurotransmitter plasticity in the PVN. J Comp Neurol (2009) 517:156–65. 
doi:10.1002/cne.22142 
47. Miyata S, Nakashima T, Kiyohara T. Structural dynamics of neural plasticity in 
the supraoptic nucleus of the rat hypothalamus during dehydration and rehy-
dration. Brain Res Bull (1994) 34:169–75. doi:10.1016/0361-9230(94)90057-4 
48. Lin SH, Miyata S, Kawarabayashi T, Nakashima T, Kiyohara T. Hypertrophy 
of oxytocinergic magnocellular neurons in the hypothalamic supraoptic 
nucleus from gestation to lactation. Zoolog Sci (1996) 13:161–5. doi:10.2108/
zsj.13.161 
49. Ma XM, Lightman SL, Aguilera G. Vasopressin and corticotropin-releasing 
hormone gene responses to novel stress in rats adapted to repeated restraint. 
Endocrinology (1999) 140:3623–32. doi:10.1210/endo.140.8.6943 
50. Ma XM, Levy A, Lightman SL. Emergence of an isolated arginine vasopres-
sin (AVP) response to stress after repeated restraint: a study of both AVP 
and corticotropin-releasing hormone messenger ribonucleic acid (RNA) 
and heteronuclear RNA. Endocrinology (1997) 138:4351–7. doi:10.1210/
endo.138.10.5446 
51. Makino S, Smith MA, Gold PW. Increased expression of corticotropin- 
releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in 
the hypothalamic paraventricular nucleus during repeated stress: association 
with reduction in glucocorticoid receptor mRNA levels. Endocrinology 
(1995) 136:3299–309. doi:10.1210/en.136.8.3299 
52. Murphy EK, Spencer RL, Sipe KJ, Herman JP. Decrements in nuclear glu-
cocorticoid receptor (GR) protein levels and DNA binding in aged rat hip-
pocampus. Endocrinology (2002) 143:1362–70. doi:10.1210/endo.143.4.8740 
53. McKay LI, Cidlowski JA. Cross-talk between nuclear factor-kappa B and 
the steroid hormone receptors: mechanisms of mutual antagonism. Mol 
Endocrinol (1998) 12:45–56. doi:10.1210/me.12.1.45 
54. Zalachoras I, Verhoeve SL, Toonen LJ, Van Weert LT, Van Vlodrop AM, 
Mol  IM, et  al. Isoform switching of steroid receptor co-activator-1 atten-
uates glucocorticoid-induced anxiogenic amygdala CRH expression. Mol 
Psychiatry (2016). doi:10.1038/mp.2016.16 
55. Verkuyl JM, Hemby SE, Joels M. Chronic stress attenuates GABAergic inhibi-
tion and alters gene expression of parvocellular neurons in rat hypothalamus. 
Eur J Neurosci (2004) 20:1665–73. doi:10.1111/j.1460-9568.2004.03568.x 
56. Franco AJ, Chen C, Scullen T, Zsombok A, Salahudeen AA, Di S, et  al. 
Sensitization of the hypothalamic-pituitary-adrenal axis in a male rat chronic 
stress model. Endocrinology (2016) 157:2346–55. doi:10.1210/en.2015-1641 
57. Cullinan WE. GABA(A) receptor subunit expression within 
hypophysiotropic CRH neurons: a dual hybridization histo-
chemical study. J Comp Neurol (2000) 419:344–51. doi:10.1002/
(SICI)1096-9861(20000410)419:3<344::AID-CNE6>3.0.CO;2-Z 
58. Zheleznova NN, Sedelnikova A, Weiss DS. Function and modulation of 
delta-containing GABA(A) receptors. Psychoneuroendocrinology (2009) 
34(Suppl 1):S67–73. doi:10.1016/j.psyneuen.2009.08.010 
59. Hewitt SA, Wamsteeker JI, Kurz EU, Bains JS. Altered chloride homeostasis 
removes synaptic inhibitory constraint of the stress axis. Nat Neurosci (2009) 
12:438–43. doi:10.1038/nn.2274 
60. Maguire J. Stress-induced plasticity of GABAergic inhibition. Front Cell 
Neurosci (2014) 8:157. doi:10.3389/fncel.2014.00157 
61. Ziegler DR, Cullinan WE, Herman JP. Organization and regulation of 
paraventricular nucleus glutamate signaling systems: N-methyl-d-aspartate 
receptors. J Comp Neurol (2005) 484:43–56. doi:10.1002/cne.20445 
62. Wamsteeker JI, Kuzmiski JB, Bains JS. Repeated stress impairs endocannabi-
noid signaling in the paraventricular nucleus of the hypothalamus. J Neurosci 
(2010) 30:11188–96. doi:10.1523/JNEUROSCI.1046-10.2010 
63. Sharp FR, Sagar SM, Hicks K, Lowenstein D, Hisanaga K. c-fos mRNA, Fos, 
and Fos-related antigen induction by hypertonic saline and stress. J Neurosci 
(1991) 11:2321–31. 
64. Cullinan WE, Herman JP, Battaglia DF, Akil H, Watson SJ. Pattern and time 
course of immediate early gene expression in rat brain following acute stress. 
Neuroscience (1995) 64:477–505. doi:10.1016/0306-4522(94)00355-9 
65. Curran T, Franza BR Jr. Fos and Jun: the AP-1 connection. Cell (1988) 
55:395–7. doi:10.1016/0092-8674(88)90024-4 
66. Campeau S, Dolan D, Akil H, Watson SJ. c-Fos mRNA induction in acute 
and chronic audiogenic stress: possible role of the orbitofrontal cortex in 
habituation. Stress (2002) 5:121–30. doi:10.1080/10253890290027895 
67. Girotti M, Pace TW, Gaylord RI, Rubin BA, Herman JP, Spencer RL. 
Habituation to repeated restraint stress is associated with lack of 
 stress-induced c-fos expression in primary sensory processing areas of the rat 
brain. Neuroscience (2006) 138:1067–81. doi:10.1016/j.neuroscience.2005. 
12.002 
68. Radley JJ, Sawchenko PE. Evidence for involvement of a limbic paraventric-
ular hypothalamic inhibitory network in hypothalamic-pituitary-adrenal 
axis adaptations to repeated stress. J Comp Neurol (2015) 523:2769–87. 
doi:10.1002/cne.23815 
69. Bhatnagar S, Dallman M. Neuroanatomical basis for facilitation of hypo-
thalamic-pituitary-adrenal responses to a novel stressor after chronic stress. 
Neuroscience (1998) 84:1025–39. doi:10.1016/S0306-4522(97)00577-0 
70. Ostrander MM, Ulrich-Lai YM, Choi DC, Flak JN, Richtand NM, Herman JP. 
Chronic stress produces enduring decreases in novel stress-evoked c-fos 
mRNA expression in discrete brain regions of the rat. Stress (2009) 12:469–77. 
doi:10.3109/10253890802641966 
71. Singewald GM, Nguyen NK, Neumann ID, Singewald N, Reber SO. Effect 
of chronic psychosocial stress-induced by subordinate colony (CSC) 
housing on brain neuronal activity patterns in mice. Stress (2009) 12:58–69. 
doi:10.1080/10253890802042082 
72. Nunez C, Martin F, Foldes A, Luisa Laorden M, Kovacs KJ, Victoria Milanes 
M. Induction of FosB/DeltaFosB in the brain stress system-related struc-
tures during morphine dependence and withdrawal. J Neurochem (2010) 
114:475–87. doi:10.1111/j.1471-4159.2010.06765.x 
73. Korosi A, Shanabrough M, Mcclelland S, Liu ZW, Borok E, Gao XB, et al. 
Early-life experience reduces excitation to stress-responsive hypothalamic 
neurons and reprograms the expression of corticotropin-releasing hormone. 
J Neurosci (2010) 30:703–13. doi:10.1523/JNEUROSCI.4214-09.2010 
74. Plotsky PM, Cunningham ET Jr, Widmaier EP. Catecholaminergic modu-
lation of corticotropin-releasing factor and adrenocorticotropin secretion. 
Endocr Rev (1989) 10:437–58. doi:10.1210/edrv-10-4-437 
75. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, 
Choi  DC, et  al. Central mechanisms of stress integration: hierarchical 
circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. 
Front Neuroendocrinol (2003) 24:151–80. doi:10.1016/j.yfrne.2003.07.001 
76. Flak JN, Myers B, Solomon MB, Mcklveen JM, Krause EG, Herman JP. Role 
of paraventricular nucleus-projecting norepinephrine/epinephrine neurons 
in acute and chronic stress. Eur J Neurosci (2014) 39:1903–11. doi:10.1111/
ejn.12587 
77. Carvalho-Netto EF, Myers B, Jones K, Solomon MB, Herman JP. Sex dif-
ferences in synaptic plasticity in stress-responsive brain regions following 
chronic variable stress. Physiol Behav (2011) 104:242–7. doi:10.1016/j.
physbeh.2011.01.024 
78. Kinzig KP, D’Alessio DA, Herman JP, Sakai RR, Vahl TP, Figueiredo HF, 
et al. CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety 
responses to interoceptive and psychogenic stressors. J Neurosci (2003) 
23:6163–70. 
79. Tauchi M, Zhang R, D’Alessio DA, Seeley RJ, Herman JP. Role of central 
glucagon-like peptide-1 in hypothalamo-pituitary-adrenocortical facilita-
tion following chronic stress. Exp Neurol (2008) 210:458–66. doi:10.1016/ 
j.expneurol.2007.11.016 
10
Herman and Tasker Stress and Paraventricular Nucleus Neuroplasticity
Frontiers in Endocrinology | www.frontiersin.org October 2016 | Volume 7 | Article 137
80. Zhang R, Jankord R, Flak JN, Solomon MB, D’Alessio DA, Herman JP. Role 
of glucocorticoids in tuning hindbrain stress integration. J Neurosci (2010) 
30:14907–14. doi:10.1523/JNEUROSCI.0522-10.2010 
81. Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic 
stress responses. Nat Rev Neurosci (2009) 10:397–409. doi:10.1038/nrn2647 
82. Choi DC, Furay AR, Evanson NK, Ulrich-Lai YM, Nguyen MM, 
Ostrander  MM, et  al. The role of the posterior medial bed nucleus of the 
stria terminalis in modulating hypothalamic-pituitary-adrenocortical axis 
responsiveness to acute and chronic stress. Psychoneuroendocrinology (2008) 
33:659–69. doi:10.1016/j.psyneuen.2008.02.006 
83. Choi DC, Evanson NK, Furay AR, Ulrich-Lai YM, Ostrander MM, 
Herman JP. The anteroventral bed nucleus of the stria terminalis differentially 
regulates hypothalamic-pituitary-adrenocortical axis responses to acute and 
chronic stress. Endocrinology (2008) 149:818–26. doi:10.1210/en.2007-0883 
84. Dong HW, Petrovich GD, Watts AG, Swanson LW. Basic organization of 
projections from the oval and fusiform nuclei of the bed nuclei of the stria 
terminalis in adult rat brain. J Comp Neurol (2001) 436:430–55. doi:10.1002/
cne.1079 
85. Choi DC, Furay AR, Evanson NK, Ostrander MM, Ulrich-Lai YM, 
Herman JP. Bed nucleus of the stria terminalis subregions differentially 
regulate hypothalamic-pituitary-adrenal axis activity: implications for the 
integration of limbic inputs. J Neurosci (2007) 27:2025–34. doi:10.1523/
JNEUROSCI.4301-06.2007 
86. Bhatnagar S, Huber R, Nowak N, Trotter P. Lesions of the posterior 
paraventricular thalamus block habituation of hypothalamic-pituitary- 
adrenal responses to repeated restraint. J Neuroendocrinol (2002) 14:403–10. 
doi:10.1046/j.0007-1331.2002.00792.x 
87. Flak JN, Solomon MB, Jankord R, Krause EG, Herman JP. Identification of 
chronic stress-activated regions reveals a potential recruited circuit in rat brain. 
Eur J Neurosci (2012) 36:2547–55. doi:10.1111/j.1460-9568.2012.08161.x 
88. Myers B, Carvalho-Netto EF, Wu C, Wick D, Solomon MB, Ulrich-Lai 
YM, et  al. Stress-activated corticolimbic efferents innervate the posterior 
hypothalamic nucleus: a novel circuit for stimulating neuroendocrine stress 
responses. 2012 Neuroscience Meeting Planner. New Orleans, LA (2012). 
525.505 p.
89. Ulrich-Lai YM, Jones KR, Ziegler DR, Cullinan WE, Herman JP. Forebrain 
origins of glutamatergic innervation to the rat paraventricular nucleus of the 
hypothalamus: differential inputs to the anterior versus posterior subregions. 
J Comp Neurol (2011) 519:1301–19. doi:10.1002/cne.22571 
90. Zheng H, Stornetta RL, Agassandian K, Rinaman L. Glutamatergic phe-
notype of glucagon-like peptide 1 neurons in the caudal nucleus of the 
solitary tract in rats. Brain Struct Funct (2015) 220:3011–22. doi:10.1007/
s00429-014-0841-6 
91. McKlveen JM, Myers B, Flak JN, Bundzikova J, Solomon MB, Seroogy 
KB, et  al. Role of prefrontal cortex glucocorticoid receptors in stress and 
emotion. Biol Psychiatry (2013) 74(9):672–9. doi:10.1016/j.biopsych.2013. 
03.024 
92. McKlveen JM, Morano RL, Fitzgerald M, Zoubovsky S, Cassella SN, 
Scheimann JR, et al. Chronic stress increases prefrontal inhibition: a mech-
anism for stress-induced prefrontal dysfunction. Biol Psychiatry (2016). 
doi:10.1016/j.biopsych.2016.03.2101 
93. Ghosal S, Bundzikova-Osacka J, Dolgas CM, Myers B, Herman JP. 
Glucocorticoid receptors in the nucleus of the solitary tract (NTS) decrease 
endocrine and behavioral stress responses. Psychoneuroendocrinology (2014) 
45:142–53. doi:10.1016/j.psyneuen.2014.03.018 
94. Tamashiro KL, Nguyen MM, Ostrander MM, Gardner SR, Ma LY, Woods SC, 
et  al. Social stress and recovery: implications for body weight and body 
composition. Am J Physiol Regul Integr Comp Physiol (2007) 293:R1864–74. 
doi:10.1152/ajpregu.00371.2007 
95. Aguilera G, Rabadan-Diehl C. Vasopressinergic regulation of the hypotha-
lamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept 
(2000) 96:23–9. doi:10.1016/S0167-0115(00)00196-8 
96. Ulrich-Lai YM, Figueiredo HF, Ostrander MM, Choi DC, Engeland WC, 
Herman JP. Chronic stress induces adrenal hyperplasia and hypertrophy 
in a subregion-specific manner. Am J Physiol Endocrinol Metab (2006) 
291:E965–73. doi:10.1152/ajpendo.00070.2006 
97. Ulrich-Lai YM, Engeland WC. Adrenal splanchnic innervation modulates 
adrenal cortical responses to dehydration stress in rats. Neuroendocrinology 
(2002) 76:79–92. doi:10.1159/000064426 
98. Figueiredo HF, Dolgas CM, Herman JP. Stress activation of cortex and 
hippocampus is modulated by sex and stage of estrus. Endocrinology (2002) 
143:2534–40. doi:10.1210/endo.143.7.8888 
99. Tinnikov AA. Responses of serum corticosterone and corticosteroid-binding 
globulin to acute and prolonged stress in the rat. Endocrine (1999) 11:145–50. 
doi:10.1385/ENDO:11:2:145 
100. Viau V, Meaney MJ. Variations in the hypothalamic-pituitary-adrenal 
response to stress during the estrous cycle in the rat. Endocrinology (1991) 
129:2503–11. doi:10.1210/endo-129-5-2503 
101. Carey MP, Deterd CH, De Koning J, Helmerhorst F, De Kloet ER. The 
influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation 
in the female rat. J Endocrinol (1995) 144:311–21. doi:10.1677/joe.0.1440311 
102. Figueiredo HF, Ulrich-Lai YM, Choi DC, Herman JP. Estrogen potentiates 
adrenocortical responses to stress in female rats. Am J Physiol Endocrinol 
Metab (2007) 292:E1173–82. doi:10.1152/ajpendo.00102.2006 
103. Albeck DS, Mckittrick CR, Blanchard DC, Blanchard RJ, Nikulina J, 
Mcewen BS, et al. Chronic social stress alters levels of corticotropin-releas-
ing factor and arginine vasopressin mRNA in rat brain. J Neurosci (1997) 
17:4895–903. 
104. Wood SK, Walker HE, Valentino RJ, Bhatnagar S. Individual differences in 
reactivity to social stress predict susceptibility and resilience to a depressive 
phenotype: role of corticotropin-releasing factor. Endocrinology (2010) 
151:1795–805. doi:10.1210/en.2009-1026 
105. Schmidt MV, Scharf SH, Sterlemann V, Ganea K, Liebl C, Holsboer F, et al. 
High susceptibility to chronic social stress is associated with a depression-like 
phenotype. Psychoneuroendocrinology (2010) 35:635–43. doi:10.1016/j.
psyneuen.2009.10.002 
106. Reber SO, Birkeneder L, Veenema AH, Obermeier F, Falk W, Straub RH, 
et al. Adrenal insufficiency and colonic inflammation after a novel chronic 
psycho-social stress paradigm in mice: implications and mechanisms. 
Endocrinology (2007) 148:670–82. doi:10.1210/en.2006-0983 
107. Keeney A, Jessop DS, Harbuz MS, Marsden CA, Hogg S, Blackburn-Munro 
RE. Differential effects of acute and chronic social defeat stress on hypothalam-
ic-pituitary-adrenal axis function and hippocampal serotonin release in mice. 
J Neuroendocrinol (2006) 18:330–8. doi:10.1111/j.1365-2826.2006.01422.x 
108. Erhardt A, Muller MB, Rodel A, Welt T, Ohl F, Holsboer F, et al. Consequences 
of chronic social stress on behaviour and vasopressin gene expression 
in the PVN of DBA/2OlaHsd mice – influence of treatment with the 
CRHR1-antagonist R121919/NBI 30775. J Psychopharmacol (2009) 23:31–9. 
doi:10.1177/0269881108089813 
109. De Jong TR, Harris BN, Perea-Rodriguez JP, Saltzman W. Physiological 
and neuroendocrine responses to chronic variable stress in male California 
mice (Peromyscus californicus): influence of social environment and 
paternal state. Psychoneuroendocrinology (2013) 38:2023–33. doi:10.1016/ 
j.psyneuen.2013.03.006 
110. McEwen BS. Allostasis and allostatic load: implications for neuropsycho-
pharmacology. Neuropsychopharmacology (2000) 22:108–24. doi:10.1016/
S0893-133X(99)00129-3 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2016 Herman and Tasker. This is an open-access article distributed 
under the terms of the Creative Commons Attribution License (CC BY). The use, 
distribution or reproduction in other forums is permitted, provided the original 
author(s) or licensor are credited and that the original publication in this journal 
is cited, in accordance with accepted academic practice. No use, distribution or 
reproduction is permitted which does not comply with these terms.
